Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses.

Using a radiomics framework to quantitatively analyze tumor shape and texture features in three dimensions, we tested its ability to objectively and robustly distinguish between benign and malignant renal masses.